NCT04750421View on ClinicalTrials.gov

Transillumination to Reduce Post-injection Complications in Aesthetic Medicine

NACompletedINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

March 1, 2018

Primary Completion Date

June 1, 2018

Study Completion Date

July 1, 2018

Conditions
E05.642.500
Interventions
DEVICE

Transillumination Venolux®

Transillumination Venolux® method was used on the other half of the face before injections to visualize veins.

Trial Locations (1)

94000

MEZI, Créteil

All Listed Sponsors
lead

Helynck, Patrick, M.D.

OTHER

NCT04750421 - Transillumination to Reduce Post-injection Complications in Aesthetic Medicine | Biotech Hunter | Biotech Hunter